Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Delayed cases of total atrioventricular block (AVB) or complete heart block can occur more than 2 days after TAVI, two new studies affirm, highlighting the utility of extended ECG monitoring after ...

“I look forward to meeting at EuroPCR with all those who want to learn more about our first clinical trial, which demonstrated that Trinity is designed to completely eliminate paravalvular leaks, ...

COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) ...

Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ ...

Aortic valve disease is a major clinical concern, and its treatment has traditionally relied on surgical aortic valve replacement (AVR) via open‐heart surgery. In recent decades, transcatheter aortic ...

The investigational transcatheter aortic valve implantation (TAVI) system will complement Abbott's Navitor™ TAVI system for aortic stenosis, a common and life-threatening heart valve disease The ...

The Evolut TAVI Platform Receives New Indication for Patients with Bicuspid Aortic Valves at Extreme, High or Intermediate Risk of Surgical Mortality DUBLIN, June 22, 2020 (GLOBE NEWSWIRE) -- ...

JenaValve Technology just added another $26.5 million to its expanding Series C round, which looks to have swelled to near $100 million. The financing round was led by RMM and Valiance, and included ...

Aortic valve disease is a condition that occurs when your aorta (the main artery of your body) and left ventricle (the lower left chamber of your heart) malfunction. The aortic valve determines how ...